Opioid Induced Constipation Drugs Market Report

Global and China Opioid Induced Constipation Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 19, 2022
  • PAGES：188
  • REPORT CODE：GMM1388822
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Opioid Induced Constipation Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Pfizer

    • Purdue Pharma

    • Ironwood Pharmaceutical Inc

    • Progenics Pharmaceuticals Inc

    • Salix Pharmaceuticals Inc

    • Shionogi & Co Ltd

    • AstraZeneca plc

    • Nektar Therapeutics

    • Merck & Co Inc

    • Mallinckrodt Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Other

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Opioid Induced Constipation Drugs Industry Overview

      • 1.1.1 Opioid Induced Constipation Drugs Market Scope and Market Segments

      • 1.1.2 Opioid Induced Constipation Drugs Industry Characteristics

      • 1.1.3 Global and China Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Opioid Induced Constipation Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Opioid Induced Constipation Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Lubiprostone

      • 1.2.2 Methyl Naltrexone Bromide

      • 1.2.3 Naldemedine

      • 1.2.4 Alvimopan

      • 1.2.5 Other

    • 1.3 Global Opioid Induced Constipation Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Opioid Induced Constipation Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Opioid Induced Constipation Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Opioid Induced Constipation Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Opioid Induced Constipation Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Opioid Induced Constipation Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Opioid Induced Constipation Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Opioid Induced Constipation Drugs Industry PEST Analysis

    • 2.3 Opioid Induced Constipation Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Opioid Induced Constipation Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Opioid Induced Constipation Drugs Industry

    Chapter 3 Global and China Opioid Induced Constipation Drugs Market, by Manufacturer

    • 3.1 Global and China Opioid Induced Constipation Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Opioid Induced Constipation Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Opioid Induced Constipation Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Opioid Induced Constipation Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Opioid Induced Constipation Drugs Market Top 3 Players

    Chapter 4 Global and China Opioid Induced Constipation Drugs Market, by Type (2017-2028)

    • 4.1 Opioid Induced Constipation Drugs Market Trend, by Type

    • 4.2 Global Opioid Induced Constipation Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Opioid Induced Constipation Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Opioid Induced Constipation Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Opioid Induced Constipation Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Opioid Induced Constipation Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Opioid Induced Constipation Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Opioid Induced Constipation Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Opioid Induced Constipation Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Opioid Induced Constipation Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Opioid Induced Constipation Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Opioid Induced Constipation Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Opioid Induced Constipation Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Opioid Induced Constipation Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Opioid Induced Constipation Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Opioid Induced Constipation Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Opioid Induced Constipation Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Opioid Induced Constipation Drugs Market Analysis

    • 7.1 North America Opioid Induced Constipation Drugs Market, by Type

    • 7.2 North America Opioid Induced Constipation Drugs Market, by Application

    • 7.3 North America Opioid Induced Constipation Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Opioid Induced Constipation Drugs Market Analysis

    • 8.1 Europe Opioid Induced Constipation Drugs Market, by Type

    • 8.2 Europe Opioid Induced Constipation Drugs Market, by Application

    • 8.3 Europe Opioid Induced Constipation Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Opioid Induced Constipation Drugs Market Analysis

    • 9.1 APAC Opioid Induced Constipation Drugs Market, by Type

    • 9.2 APAC Opioid Induced Constipation Drugs Market, by Application

    • 9.3 APAC Opioid Induced Constipation Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Opioid Induced Constipation Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Opioid Induced Constipation Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Opioid Induced Constipation Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Opioid Induced Constipation Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Opioid Induced Constipation Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Opioid Induced Constipation Drugs Company Profiles

      • 11.1 Pfizer

        • 11.1.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Pfizer Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.1.3 Pfizer Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Purdue Pharma

        • 11.2.1 Purdue Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Purdue Pharma Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.2.3 Purdue Pharma Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ironwood Pharmaceutical Inc

        • 11.3.1 Ironwood Pharmaceutical Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ironwood Pharmaceutical Inc Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.3.3 Ironwood Pharmaceutical Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Progenics Pharmaceuticals Inc

        • 11.4.1 Progenics Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Salix Pharmaceuticals Inc

        • 11.5.1 Salix Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Salix Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.5.3 Salix Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Shionogi & Co Ltd

        • 11.6.1 Shionogi & Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Shionogi & Co Ltd Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.6.3 Shionogi & Co Ltd Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 AstraZeneca plc

        • 11.7.1 AstraZeneca plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 AstraZeneca plc Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.7.3 AstraZeneca plc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Nektar Therapeutics

        • 11.8.1 Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Nektar Therapeutics Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.8.3 Nektar Therapeutics Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Merck & Co Inc

        • 11.9.1 Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Merck & Co Inc Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.9.3 Merck & Co Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Mallinckrodt Pharmaceuticals

        • 11.10.1 Mallinckrodt Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Mallinckrodt Pharmaceuticals Opioid Induced Constipation Drugs Product Profiles, Application and Specification

        • 11.10.3 Mallinckrodt Pharmaceuticals Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Opioid Induced Constipation Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Opioid Induced Constipation Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Opioid Induced Constipation Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Opioid Induced Constipation Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Opioid Induced Constipation Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Opioid Induced Constipation Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Opioid Induced Constipation Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Opioid Induced Constipation Drugs Market Share, by Manufacturer in 2022

    • Table Global Opioid Induced Constipation Drugs Sales Volume, by Type (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Sales Value, by Type (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Price Trend, by Type (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Volume, by Type (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Value, by Type (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Price Trend, by Type (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Sales Volume, by Application (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Sales Value, by Application (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Opioid Induced Constipation Drugs Sales Value Share, by Application (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Volume, by Application (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Value, by Application (2017-2028)

    • Table China Opioid Induced Constipation Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Opioid Induced Constipation Drugs Sales Volume, by Type (2017-2028)

    • Table North America Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Opioid Induced Constipation Drugs Sales Volume, by Application (2017-2028)

    • Table North America Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Opioid Induced Constipation Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Opioid Induced Constipation Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Opioid Induced Constipation Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Opioid Induced Constipation Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Opioid Induced Constipation Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Opioid Induced Constipation Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Opioid Induced Constipation Drugs Sales Value and Growth Rate (2017-2028)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Purdue Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Purdue Pharma Product Profiles, Application and Specification

    • Table Purdue Pharma Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ironwood Pharmaceutical Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ironwood Pharmaceutical Inc Product Profiles, Application and Specification

    • Table Ironwood Pharmaceutical Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Progenics Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Progenics Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Salix Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Salix Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Salix Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shionogi & Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shionogi & Co Ltd Product Profiles, Application and Specification

    • Table Shionogi & Co Ltd Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca plc Product Profiles, Application and Specification

    • Table AstraZeneca plc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nektar Therapeutics Product Profiles, Application and Specification

    • Table Nektar Therapeutics Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co Inc Product Profiles, Application and Specification

    • Table Merck & Co Inc Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mallinckrodt Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mallinckrodt Pharmaceuticals Product Profiles, Application and Specification

    • Table Mallinckrodt Pharmaceuticals Opioid Induced Constipation Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US